Antibodies to native and denatured type II collagen in children with rheumatic diseases

Insights

Children with rheumatic diseases, including juvenile rheumatoid arthritis, show higher levels of antibodies to type II collagen (IIC). This finding suggests a potential link between IIC antibodies and various pediatric rheumatic conditions.

Area of Science:

  • Immunology
  • Rheumatology
  • Pediatric Medicine

Background:

  • Rheumatic diseases in children encompass a range of autoimmune and inflammatory conditions.
  • Type II collagen (IIC) is a major structural protein in cartilage, making it a potential autoantigen in joint diseases.
  • Antibodies to native (n) and denatured (d) forms of IIC may play a role in the pathogenesis of rheumatic diseases.

Purpose of the Study:

  • To investigate the prevalence of antibodies to native and denatured type II collagen (IIC) in children with rheumatic diseases.
  • To compare antibody levels in children with various rheumatic conditions to those in non-rheumatic control groups.

Main Methods:

  • Sera from 153 children with rheumatic diseases were analyzed using enzyme-linked immunosorbent assay (ELISA).
  • Antibodies to native (n) and denatured (d) type II collagen (IIC) were quantified.
  • Comparison was made with sera from non-rheumatic disease control groups.

Main Results:

  • Antibodies to nIIC were detected in 47% of children with juvenile rheumatoid arthritis (JRA), 70% with adult-onset RA, and 21-37% with other rheumatic diseases.
  • Antibodies to dIIC showed similar prevalence, found in 42% of JRA patients and 67% of adult-onset RA patients.
  • Prevalence of both antibody types was significantly higher in rheumatic disease groups compared to controls (less than 1-6%).

Conclusions:

  • Children with a variety of rheumatic diseases exhibit a significantly higher frequency of antibodies to both native and denatured type II collagen (IIC).
  • These findings suggest that IIC antibodies may be implicated in the development or progression of pediatric rheumatic diseases.
  • Further research is warranted to explore the specific role of IIC antibodies in the immunopathogenesis of childhood rheumatic conditions.

Related Concept Videos

Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can exist in...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...